FDA Inspection 1115560 — Genicon, Inc.

Genicon, Inc. — FEI 3002590791

The FDA completed an inspection of Genicon, Inc. on January 17, 2020 in Winter Park, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 15 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 17, 2020
Fiscal Year
2020
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Winter Park, FL (United States)

Citations

IDCFRDescription
1471121 CFR 820.160(a)Lack of or inadequate procedures for distribution
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
265021 CFR 820.30(f)Design verification - Lack of or inadequate procedures
310121 CFR 820.30(g)Design validation- Lack of or inadequate procedures
310321 CFR 820.30(i)Design changes - Lack of or Inadequate Procedures
312121 CFR 820.80(b)Lack of or inadequate receiving acceptance procedures
313021 CFR 820.100(a)Lack of or inadequate procedures
367821 CFR 820.30(g)Design Validation - Risk analysis not performed/inadequate
41921 CFR 820.20(b)Lack of or inadequate organizational structure
419221 CFR 806.10(a)(2)Report of violation of the Act (see 803.52(e)(9))
47921 CFR 820.50Purchasing controls, Lack of or inadequate procedures
54621 CFR 820.75(a)Lack of or inadequate process validation
63221 CFR 803.17(a)(2)Lack of System for Determining MDR Events
73121 CFR 803.50(a)(1)Report of Death or Serious Injury
73221 CFR 803.50(a)(2)Individual Report of Malfunction